Stephen Phillips has extensive experience in the biopharmaceutical industry, notably serving as Head of Assets & Operations in the Immunology Patient Value Unit at UCB BioPharma from March 2015 to April 2022. Currently, Stephen is the Early Development Leader for Respiratory and Immunology at GSK, overseeing the strategic and operational aspects of medicine development from Candidate Selection to end of phase 2. Previous roles include Senior Project Manager for Cimzia at UCB BioPharma, Director and Head of Molecular Cell Biology and Pharmacology at Pfizer, and Senior Scientist & Study Director at Covance. Stephen's academic credentials include a Ph.D. in Molecular Biology from the University of Liverpool and an MBA from The Open University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices